• ImmuneOncia Therapeutics will host an investor relations briefing in Seoul on Oct. 22, 2026.
• The in-person event runs from 2 p.m. to 5 p.m. local time for domestic institutional investors and securities analysts.
• Presentations will cover business operations and pipeline research progress, followed by a question-and-answer session.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ImmuneOncia Therapeutics Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261015900250), on October 15, 2026, and is solely responsible for the information contained therein.